LUTRONIC's Innovative Aesthetic and Medical Products Featured at the 13th Anti-Aging Medicine World Congress
Fremont, CA (PRWEB) April 02, 2015 -- Lutronic, a leading innovator of aesthetic and medical technology, announced today that it expands its portfolio of innovative medical solutions in Europe with ACTION II Petit Lady ™ at the 13th Anti-Aging Medicine World Congress (AMWC) in Monte-Carlo, Monaco, from March 26-28, 2015. ACTION II is a device that provides a new dimension in Er:YAG laser technology applied for both gynecological and aesthetic indications. It received CE mark clearance for treatment of vaginal relaxation syndrome (VRS) and stress urinary incontinence (SUI) in June 2014, which expands its clinical applications and builds on the success of the original ACTION II device which primarily focused on aesthetic treatments.
“I have seen that ACTION II Petit Lady increases the elasticity of the vaginal wall with a significantly short downtime. Patients suffering from vaginal relaxation syndrome are very satisfied with Petit Lady because this 15-minute non-surgical treatment successfully rejuvenates the vagina and enhances sexual gratification,” said Dr Fabio Marini, a surgeon at the Skin Laser Clinic, in Italy. Dr Marini was presenting on the Petit Lady system at a special dinner Symposium during the AMWC, ‘Symposia L’, hosted by Lutronic. Dr Marini also presented his one year clinical study on ACTION II Petit Lady for vaginal atrophy and vaginal relaxation syndrome, which showed significant improvements in both sets of patients.
The well-attended symposium, which was moderated by Dr R Glen Calderhead, VP Medicoscientific Affairs for Lutronic, also featured Dr. Matteo Tretti Clementoni, a plastic surgeon at Skin House in Italy Dr Clementoni, a world-renowned physician, shared his knowledge of the INFINI™ for treating neck and low face laxity with its High Intensity Focused RF. "The device is very easy to use, and it is possible to perform full face and neck treatment in less than 15 minutes. With varying energy, pulse duration, depth of needles penetration and number of passages, it is possible to customize the treatment for the specific skin needs of each patient on an individual basis. Finally, we have a device/treatment that really allows us to obtain good results on the lower 1/3 of the face and the neck,” he added. Another presenter of INFINI, Dr Harryono Judodihardjo, a dermatologist from the Cellite Clinic, UK also shared his clinical experiences with the title, ‘How to Smooth Out Accordion Lines (Smile Lines).’
Another star speaker was Dr Christine Dierickx, a world-wide respected dermatologist from Skinperium, Belgium, who presented on the Q-switched Nd:YAG-based multiplatform, SPECTRA XT™, which is the latest edition of the cutting-edge SPECTRA family of lasers, already best-known and appreciated for its versatility and reliability.
The symposium was a great success, judging from the many favorable comments from the attendees who were most impressed by the practical and solid nature of the presentations and the range of topics covered by the well-appreciated presenters. This symposium built on the success of the similar event at last year’s AMWC, and many of those present stated that they would definitely be looking to attend again next year, hoping that it will become a tradition to be established by Lutronic at subsequent AMWC meetings.
About ACTION II Petit Lady
The Lutronic ACTION Petit Lady is a 360° solution for cosmetic gynecology. The treatment is gentle, simple and fast. The ACTION II Petit Lady 360° handpiece is specially designed for VRS. It delivers multiple micropulses to the vaginal mucosa to stimulate collagen remodeling and tighten the vaginal canal. The ACTION II Petit Lady 90º handpiece is intended for SUI, providing an enhanced thermal and shrinkage effect in the endopelvic fascia, ligaments, and mucosal tissue of the anterior vaginal canal.
To learn more about the ACTION II Petit Lady, please visit: http://www.petitlady.net/
About LUTRONIC
Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 18 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more.
With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 240 intellectual properties including current and pending patents worldwide. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.
For more information about Lutronic and its products, please visit: http://www.lutronic.com
Jennifer Ahn, Lutronic Inc., http://www.lutronic.com, +82 7047146039, [email protected]
Share this article